Welcome to
RBP World!
Ensembl ID | ENSG00000110713 | Gene ID | 4928 | Accession | 8068 |
Gene Symbol | NUP98 | Alias | ADIR2;NUP96;NUP196;Nup98-96 | Full Name | nucleoporin 98 and 96 precursor |
Position | 11 : 3671083 - 3797792 | Length | 126710 bases | Strand | Minus strand |
Status | Confidence | Main interacting RNAs | N.A. | RBP type | Non-canonical_RBPs |
Summary | Nuclear pore complexes (NPCs) regulate the transport of macromolecules between the nucleus and cytoplasm, and are composed of many polypeptide subunits, many of which belong to the nucleoporin family. This gene belongs to the nucleoporin gene family and encodes a 186 kDa precursor protein that undergoes autoproteolytic cleavage to generate a 98 kDa nucleoporin and 96 kDa nucleoporin. The 98 kDa nucleoporin contains a Gly-Leu-Phe-Gly (GLGF) repeat domain and participates in many cellular processes, including nuclear import, nuclear export, mitotic progression, and regulation of gene expression. The 96 kDa nucleoporin is a scaffold component of the NPC. Proteolytic cleavage is important for targeting of the proteins to the NPC. Translocations between this gene and many other partner genes have been observed in different leukemias. Rearrangements typically result in chimeras with the N-terminal GLGF domain of this gene to the C-terminus of the partner gene. Alternative splicing results in multiple transcript variants encoding different isoforms, at least two of which are proteolytically processed. Some variants lack the region that encodes the 96 kDa nucleoporin. [provided by RefSeq, Feb 2016] |
ENSG00000110713 Expression In 33 Tumors
Ensembl ID | Gene symbol | Log2 Foldchange | Pvaue | Cancer |
---|
Ensembl ID | Gene symbol | Cancer types | Pubmed ID |
---|---|---|---|
ENSG00000110713 | tumor | 10502319 | |
ENSG00000110713 | AML | 10556215 | |
ENSG00000110713 | AML | 10583265 | |
ENSG00000110713 | AML | 10700860 | |
ENSG00000110713 | AML | 10848835 | |
ENSG00000110713 | acute myeloid leukemia (AML) | 10936866 | |
ENSG00000110713 | AML | 10959088 | |
ENSG00000110713 | acute myeloid leukemia (AML) | 11157742 | |
ENSG00000110713 | AML | 11241795 | |
ENSG00000110713 | AML | 11681408 | |
ENSG00000110713 | acute myeloid leukemia (AML) | 11737860 | |
ENSG00000110713 | AML | 11830496 | |
ENSG00000110713 | AML | 11895789 | |
ENSG00000110713 | tumors | 12032333 | |
ENSG00000110713 | acute myeloid leukemia (AML) | 12112533 | |
ENSG00000110713 | acute myeloid leukemia (AML) | 12543865 | |
ENSG00000110713 | AML | 12874791 | |
ENSG00000110713 | AML | 12970787 | |
ENSG00000110713 | AML | 15036893 | |
ENSG00000110713 | tumors | 15182531 | |
ENSG00000110713 | AML-M2 | 15721637 | |
ENSG00000110713 | tumors | 16282337 | |
ENSG00000110713 | AML-M0 | 16419055 | |
ENSG00000110713 | acute myeloid leukemia (AML) | 16861351 | |
ENSG00000110713 | tumor | 16939812 | |
ENSG00000110713 | thymic tumors | 17429429 | |
ENSG00000110713 | acute myeloid leukemia (AML) | 17442773 | |
ENSG00000110713 | tumor | 18223676 | |
ENSG00000110713 | AML | 18264136 | |
ENSG00000110713 | acute myeloid leukemia (AML) | 18375036 | |
ENSG00000110713 | Acute myeloid leukemia (AML) | 19225539 | |
ENSG00000110713 | acute myeloid leukemia (AML) | 19430464 | |
ENSG00000110713 | AML M4 | 19665070 | |
ENSG00000110713 | AML | 21130494 | |
ENSG00000110713 | AML | 21467841 | |
ENSG00000110713 | AML | 21471525 | |
ENSG00000110713 | AML | 21810091 | |
ENSG00000110713 | acute myeloid leukemia (AML) | 21813447 | |
ENSG00000110713 | acute myeloid leukemia (AML) | 21867644 | |
ENSG00000110713 | Tumor | 22606303 | |
ENSG00000110713 | acute myeloid leukemia (AML) | 22885519 | |
ENSG00000110713 | pediatric AML | 23531517 | |
ENSG00000110713 | AML | 23630019 | |
ENSG00000110713 | AML | 23847761 | |
ENSG00000110713 | AMLs | 23936658 | |
ENSG00000110713 | tumors | 24213499 | |
ENSG00000110713 | acute myeloid leukemia (AML) | 24535671 | |
ENSG00000110713 | cancers | 24874471 | |
ENSG00000110713 | acute myeloid leukemia (AML) | 25145343 | |
ENSG00000110713 | acute myeloid leukemia (AML) | 25301331 | |
ENSG00000110713 | AML | 25487151 | |
ENSG00000110713 | tumor | 25741594 | |
ENSG00000110713 | AML | 26004809 | |
ENSG00000110713 | AML | 26071460 | |
ENSG00000110713 | AML | 26418229 | |
ENSG00000110713 | AML | 26684393 | |
ENSG00000110713 | cancers | 26731471 | |
ENSG00000110713 | acute myeloid leukemia (AML) | 27031510 | |
ENSG00000110713 | acute myeloid leukemia (AML) | 27060678 | |
ENSG00000110713 | cancer | 27144525 | |
ENSG00000110713 | pediatric AML | 27694926 | |
ENSG00000110713 | acute myeloid leukemia (AML) | 27890253 | |
ENSG00000110713 | AML | 27890935 | |
ENSG00000110713 | tumors | 28117658 | |
ENSG00000110713 | AML | 28521413 | |
ENSG00000110713 | pediatric AML | 28710806 | |
ENSG00000110713 | AML | 28854430 | |
ENSG00000110713 | AML | 29034209 | |
ENSG00000110713 | AMLs | 29075615 | |
ENSG00000110713 | AML | 29326122 | |
ENSG00000110713 | AML | 29527516 | |
ENSG00000110713 | cancers | 30361777 | |
ENSG00000110713 | acute myeloid leukemia (AML) | 30378313 | |
ENSG00000110713 | Acute myeloid leukemia (AML) | 30568173 | |
ENSG00000110713 | AML | 30700838 | |
ENSG00000110713 | AML-M2 | 30848074 | |
ENSG00000110713 | breast cancer | 30935371 | |
ENSG00000110713 | acute myeloid leukemia (AML) | 31134509 | |
ENSG00000110713 | AML | 31137568 | |
ENSG00000110713 | cancer | 31190890 | |
ENSG00000110713 | AML | 31207999 | |
ENSG00000110713 | AML | 31213012 | |
ENSG00000110713 | AML | 31467532 | |
ENSG00000110713 | AML | 31473470 | |
ENSG00000110713 | AML | 31681706 | |
ENSG00000110713 | AML | 31709264 | |
ENSG00000110713 | acute myeloid leukemia (AML) | 9858599 |
Ensembl ID | Gene symbol | Cancer | P-value | Which worse | show |
---|---|---|---|---|---|
ENSG00000110713 | MESO | 0.0031 | high | ||
ENSG00000110713 | SARC | 0.05 | high | ||
ENSG00000110713 | UVM | 0.0076 | high | ||
ENSG00000110713 | PAAD | 0.01 | high | ||
ENSG00000110713 | ACC | 0.00029 | high | ||
ENSG00000110713 | LUSC | 0.0071 | high | ||
ENSG00000110713 | READ | 0.008 | low | ||
ENSG00000110713 | KIRP | 0.0022 | high | ||
ENSG00000110713 | KICH | 0.00013 | high | ||
ENSG00000110713 | PCPG | 0.023 | high | ||
ENSG00000110713 | ESCA | 0.05 | low | ||
ENSG00000110713 | OV | 0.012 | high | ||
ENSG00000110713 | PRAD | 0.037 | high | ||
ENSG00000110713 | LAML | 0.015 | low | ||
ENSG00000110713 | GBM | 0.0034 | high | ||
ENSG00000110713 | SKCM | 0.0034 | low | ||
ENSG00000110713 | LIHC | 0.0023 | high |
Ensembl ID | Gene symbol | Cancer | CNV type | -log10(q-value) | G-score | average amplitude | frequency |
---|---|---|---|---|---|---|---|
ENSG00000110713 | LUSC | Del | 10.608143 | 0.154078 | 0.372456 | 0.479042 | |
ENSG00000110713 | LUAD | Del | 1.367546 | 0.060217 | 0.296792 | 0.257752 | |
ENSG00000110713 | LGG | Del | 9.286342 | 0.100456 | 0.570421 | 0.198830 | |
ENSG00000110713 | SARC | Del | 1.355587 | 0.140702 | 0.510419 | 0.396887 | |
ENSG00000110713 | GBM | Del | 1.353383 | 0.060231 | 0.484522 | 0.207972 | |
ENSG00000110713 | PAAD | Del | 1.641919 | 0.064724 | 0.336912 | 0.152174 | |
ENSG00000110713 | ESCA | Del | 0.820833 | 0.100616 | 0.362581 | 0.407609 | |
ENSG00000110713 | HNSC | Del | 2.809139 | 0.075703 | 0.366627 | 0.312261 | |
ENSG00000110713 | PCPG | Del | 1.688309 | 0.078860 | 0.626959 | 0.358025 | |
ENSG00000110713 | BLCA | Del | 2.197427 | 0.101100 | 0.434266 | 0.531863 | |
ENSG00000110713 | BRCA | Del | 10.916594 | 0.118290 | 0.432397 | 0.275926 | |
ENSG00000110713 | STAD | Del | 0.677750 | 0.060147 | 0.349512 | 0.213152 | |
ENSG00000110713 | UCEC | Del | 2.842297 | 0.071105 | 0.521210 | 0.187384 | |
ENSG00000110713 | OV | Del | 31.515381 | 0.459799 | 0.604409 | 0.590674 |